AlphaStocks
2.9
Avoid

STERIS plc (STE)

Health Care / Health Care Equipment

S&P 500

$214.49

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 5 of 5 models — high confidence

#1023out of 1126 in Health Care

Is STERIS plc a Good Investment in 2026?

STERIS plc (STE) scores 2.9 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates STERIS plc as Attractive (5/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. STERIS plc currently trades above its estimated fair value of $153, suggesting limited upside at current prices. STERIS plc ranks #1023 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E34.6ROE9.4Market Cap21BDiv Yield1.0

Estimated Fair Value

$152.8840% above

Trading above estimated fair value. Rapid eps growth (63%) partially justifies the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

PEG 2.0 · Fast Grower

Greenblatt

Neutral

Top half (rank 41%)

Frequently Asked Questions

Is STERIS plc (STE) a good investment?
Based on AlphaStocks' composite analysis, STERIS plc (STE) scores 2.9 out of 10, earning a Avoid rating. This score is below average, suggesting caution. Trading above estimated fair value. Rapid eps growth (63%) partially justifies the premium.
What is STERIS plc's Piotroski F-Score?
STERIS plc's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is STE overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $153, STE appears overvalued. The stock currently trades 40% above its estimated fair value. Trading above estimated fair value. Rapid eps growth (63%) partially justifies the premium.
How does STE compare to other Health Care stocks?
STERIS plc ranks #1023 out of 1126 stocks in the Health Care sector, placing it in the top 91% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about STE?
AlphaStocks evaluates STE using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 2.9/10.

Similar Stocks

PARRAZNFTI

Compare STE with

STE vs PARRSTE vs AZNSTE vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer